Related Experiment Video
Updated: Nov 22, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Regulation of p53 stability as a therapeutic strategy for cancer
Zhifei Xu1, Wentong Wu1, Hao Yan1
1Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Abstract:
The tumor suppressor protein p53 participates in the control of key biological functions such as cell death, metabolic homeostasis and immune function, which are closely related to various diseases such as tumors, metabolic disorders, infection and neurodegeneration. The p53 gene is also mutated in approximately 50% of human cancer cells. Mutant p53 proteins escape from the ubiquitination-dependent degradation, gain oncogenic function and promote the carcinogenesis, malignant progression, metastasis and chemoresistance. Therefore, the stability of both wild type and mutant p53 needs to be precisely regulated to maintain normal functions and targeting the p53 stability is one of the therapeutic strategies against cancer. Here, we focus on compound-induced degradation of p53 by both the ubiquitination-dependent proteasome and autophagy-lysosome degradation pathways. We also review other posttranslational modifications which control the stability of p53 and the biological functions involved in these processes. This review provides the current theoretical basis for the regulation of p53 abundance and its possible applications in different diseases.
Insights
This review explores how compounds degrade the tumor suppressor protein p53, crucial for cell death and homeostasis. Understanding p53 stability regulation offers new therapeutic strategies for cancer and other diseases.
Area of Science:
- Molecular Biology
- Biochemistry
- Oncology
Background:
- The tumor suppressor protein p53 regulates vital biological functions including cell death, metabolic homeostasis, and immune responses.
- Mutations in the p53 gene occur in about 50% of human cancers, leading to oncogenic functions that promote tumor progression and chemoresistance.
- Precise regulation of both wild-type and mutant p53 stability is essential for normal cellular functions and represents a key therapeutic target in cancer treatment.
Purpose of the Study:
- To review compound-induced degradation of p53 through proteasome and autophagy-lysosome pathways.
- To discuss other post-translational modifications influencing p53 stability and biological functions.
- To provide a theoretical basis for p53 abundance regulation and its therapeutic applications in various diseases.
Main Methods:
- Literature review focusing on compound-induced p53 degradation mechanisms.
- Analysis of ubiquitination-dependent proteasome and autophagy-lysosome pathways in p53 regulation.
- Examination of various post-translational modifications affecting p53 stability.
Main Results:
- Compounds can induce p53 degradation via both the ubiquitination-dependent proteasome and autophagy-lysosome pathways.
- Post-translational modifications significantly control p53 stability and its associated biological functions.
- Targeting p53 stability through compound-induced degradation is a promising therapeutic strategy.
Conclusions:
- The regulation of p53 stability is critical for maintaining normal cellular functions and preventing diseases like cancer.
- Understanding the mechanisms of p53 degradation offers potential therapeutic avenues for cancer and other p53-related disorders.
- This review consolidates current knowledge on p53 stability regulation, highlighting its implications for disease treatment.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Drugs that Stabilize Microtubules

